กำลังโหลด
NASDAQTechnologySoftware - Application
ข้อมูลล่าสุด
US$8.30
−US$0.10 · -1.19%
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
ราคาปิดก่อนหน้า
US$8.30
−US$0.10 · -1.19%
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
ช่วงราคารายวัน
ปัจจุบัน US$8.30
ช่วง 52 สัปดาห์
ปัจจุบัน US$8.30
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
คะแนน GoAI
ถือ
มูลค่า
65
ต่ำกว่ามูลค่า
ความเชื่อมั่น
48
ผสม
ความเสี่ยง
43
ความเสี่ยงค่อนข้างสูง
โมเมนตัม
52
เป็นกลาง
งานวิจัย GoAI ฉบับเต็ม
ดูข้อมูลสนับสนุน ปัจจัยหนุน และความเสี่ยงในเชิงลึก
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
ช่วงราคารายวัน
ปัจจุบัน US$8.30
ช่วง 52 สัปดาห์
ปัจจุบัน US$8.30
อัตรากำไรที่รายงานในช่วงเวลาที่มีอยู่
รายได้
รายได้จากการดำเนินงาน
รายได้สุทธิ
| รายการ (EUR) | ปีงบประมาณ 2025 | ปีงบประมาณ 2024 | ปีงบประมาณ 2023 | ปีงบประมาณ 2022 | ปีงบประมาณ 2021 |
|---|---|---|---|---|---|
| รายได้ | 257.07M EUR | 266.77M EUR | 256.13M EUR | 232.02M EUR | 205.45M EUR |
| ต้นทุนสินค้าขาย | 110.16M EUR | 115.94M EUR | 111M EUR | 103.26M EUR | 87.28M EUR |
| กำไรขั้นต้น | 146.91M EUR | 150.83M EUR | 145.13M EUR | 128.77M EUR | 118.17M EUR |
| การวิจัยและพัฒนา | 44.27M EUR | 44.4M EUR | 38.1M EUR | 37.57M EUR | 26.89M EUR |
| การขาย ทั่วไป และธุรการ | 96.32M EUR | 101.22M EUR | 94.89M EUR | 93.02M EUR | 77.59M EUR |
| ค่าใช้จ่ายในการดำเนินงาน | 141.97M EUR | 141.39M EUR | 139.51M EUR | 131.64M EUR | 105.96M EUR |
| รายได้ดอกเบี้ย | 3.81M EUR | 4.25M EUR | 4.45M EUR | 1.4M EUR | 777.74K EUR |
| ดอกเบี้ยจ่าย | 5.39M EUR | 1.65M EUR | 2.09M EUR | 2.92M EUR | 3.36M EUR |
| ค่าเสื่อมราคาและค่าตัดจำหน่าย | 20.85M EUR | 21.76M EUR | 21.57M EUR | 22.57M EUR | 20.55M EUR |
| รายได้จากการดำเนินงาน | 4.94M EUR | 9.43M EUR | 5.62M EUR | −2.87M EUR | 12.22M EUR |
| รายได้สุทธิ | 7.41M EUR | 13.44M EUR | 6.72M EUR | −2.12M EUR | 13.15M EUR |
ข้อเท็จจริงของบริษัทได้รับการปรับปรุง 11 ต.ค. 2569.
ผลประกอบการล่าสุดที่ประกาศ
ผลประกอบการล่าสุดที่ประกาศ
ประมาณการของนักวิเคราะห์ภายนอกอาจเปลี่ยนแปลงและไม่ใช่คำแนะนำของ GoAI
เป้าหมายเฉลี่ย
US$10.00
โอกาสปรับขึ้น 20.48%กองทุนซื้อขายแลกเปลี่ยนที่รายงานความเสี่ยงต่อหุ้นนี้
The 3D Printing ETFPRNT2.87M4.64%58.7M USD0.66%US$25.50+0.80%
Pacer BlueStar Engineering the Future ETFBULD328.78K2.21%14.88M USD0.49%US$37.238+0.94%
ActivePassive International Equity ETFAPIE254.74K0.02%1.14B USD0.45%US$38.56+0.65%
State Street SPDR S&P International Small Cap ETFGWX216.35K0.02%907.87M USD0.40%US$45.56+0.93%
State Street SPDR Portfolio Developed World ex-US ETFSPDW83.35K0.00%40.46B USD0.03%US$49.98+0.64%The 3D Printing ETFPRNTPacer BlueStar Engineering the Future ETFBULDActivePassive International Equity ETFAPIEState Street SPDR S&P International Small Cap ETFGWXState Street SPDR Portfolio Developed World ex-US ETFSPDWเนื้อหาที่สร้างโดย AI และข้อมูลตลาดที่ล่าช้ามีไว้เพื่อให้ข้อมูลและการศึกษาเท่านั้น ไม่ใช่คำแนะนำการลงทุน
